Pemtumomab
|
WikiDoc Resources for Pemtumomab |
|
Articles |
|---|
|
Most recent articles on Pemtumomab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Pemtumomab at Clinical Trials.gov Clinical Trials on Pemtumomab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Pemtumomab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Pemtumomab Discussion groups on Pemtumomab Patient Handouts on Pemtumomab Directions to Hospitals Treating Pemtumomab Risk calculators and risk factors for Pemtumomab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Pemtumomab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Pemtumomab (formerly known as Theragyn) is a mouse monoclonal antibody which it's used to treat cancer.
External link
Template:Mousemonoclonals
Template:WH
Template:WikiDoc Sources